IL33 and cervical carcinoma: In breast and cervical cancer, increased expression of IL-33 has been observed in tumor cells from patients with LN metastases (72, 73), suggesting that IL-33/ST2 might participate in invasion and metastasis by remodeling primary and metastatic tumor microenvironment.